Pay in 4 interest-free payments of $5.46 Learn more
Ships within 48 hours · Estimated delivery Oct 16 - Oct 21
cronos group glp-1 receptor agonist weight management diabetes treatments GLP-1-directed NMDA antagonism for obesity treatment Supply Options:1 Month Supply 90 VC The Impact of GLP-1
The Impact of GLP-1 Use On Food Companies | Creative Energy
Over 1.5 years, patients who took Zepbound lost ~21% of their body weight, and an incredible 83% of them lost more than 10% of their body weight
90 VC
Supply Options:1 Month Supply
In 2023, the Indian GLP-1 market was valued at USD 105.7 million and is projected to grow at a CAGR of 27.5%, reaching approximately USD 578.9 million by 2030
US$ 23.12
US$ 22.78
US$ 25.56
US$ 23.56
US$ 29.33
US$ 28.44
